BRG Share Price Performance
NOK 141.00
-45.40 (-24.36%)
23.3% undervalued intrinsic discount
NOK 183.80
Fair Value
Price NOK 141.00
AnalystConsensusTarget NOK 183.80
Fair ValueNOK 183.80
Share Pricen/a
Narrative Update • Jun 04
Borregaard ASA Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
BRG Community Narratives
AN
Fair Value
·Fair Value NOK 183.8 23.3% undervalued intrinsic discount
Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments
0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
Analysts Adjust Borregaard Price Target and Valuation Following Recent Updates and Ongoing Developments
Borregaard looks set to benefit as more customers shift toward greener chemicals and higher-value specialty products, while operational upgrades and currency protection may help smooth out bumps along the way. But new trade barriers, rising input and shipping costs, and heavy exposure to farming could quickly test how durable that momentum really is.Read more
AN
NOK 183.8
23.3% undervalued intrinsic discount
Fair Value
Revenue
4.82% p.a.
Profit Margin
15.73%
Future PE
16.19x
Price in 2029
NOK 223.94
Trending Discussion
Recently Updated Narratives
AN
BRG: Dividend Support And Margin Resilience Will Underpin Future Upside
Fair Value: NOK 183.8 23.3% undervalued intrinsic discount
13 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Borregaard ASA Key Details
Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 16, 2026
- 5.51
- 64.71%
- 7.17%
- 26.6%
About BRG
- Founded
- 2012
- Employees
- 1193
- CEO
- WebsiteView website
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment develops, produces, and sells biopolymers and biovanillin derived from lignin for agrochemicals, batteries, industrial binders, and construction, as well as to flavor and fragrance companies, and food and beverage industry. Its BioMaterials segment develops, produces, and sells speciality cellulose used as a raw material in the production of cellulose ethers, cellulose acetate, and other specialty products, as well as cellulose fibrils for industrial applications. The Fine Chemicals segment supplies fine chemical intermediates for contrast agents and advanced bioethanol. The company was incorporated in 2012 and is headquartered in Sarpsborg, Norway.
